They found that knockdown (KD) or KO of EI24 utilizing siRNA or CRISPR/Cas9, respectively, impaired pancreatic cancer autophagy and then suppressed cell proliferation [187]. This evidence concerns the gene EI24 and familial pancreatic carcinoma.